Shearman & Sterling advised Merrill Lynch Far East Limited and Goldman Sachs (Asia) L.L.C. as joint sponsors and Merrill Lynch (Asia Pacific) Limited, Goldman Sachs (Asia) L.L.C., CLSA Limited and Haitong International Securities Company Limited as joint global coordinators and joint bookrunners on the $204 million global offering and initial public offering of Frontage Holdings Corporation (Frontage) on the Main Board of The Stock Exchange of Hong Kong Limited.
Frontage priced its offering at HK$3.20 (approximately US$0.41) per offer share and offered 501,910,000 global offering shares, subject to the overallotment option.
Founded in 2001, Frontage is a fast-growing contract research organization providing integrated, scientifically driven research, analytical and development services throughout the drug discovery and development process to enable pharmaceutical companies to achieve their drug development goals.
The Shearman & Sterling team below included staff attorney Jared Sint.